Cardiac contractile dysfunction in J2N-k cardiomyopathic hamsters is associated with impaired SR function and regulation

American Journal of Physiology - Cell Physiology

Volumn 287, Issue 5 56-5, 2004, Pages

  Babick, Andrea P ^a   Cantor, Elliott J F ^a   Babick, John T ^a   Takeda, Nobuakira ^b   Dhalla, Naranjan S ^a   Netticadan, Thomas ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Ca 2+ calmodulin dependent protein kinase; cAMP dependent protein kinase; Cardiomyopathy; Phospholamban; Sarco(endo)plasmic reticulum ATPase; Sarcoplasmic reticulum

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM ION; COMPLEMENTARY DNA; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; PHOSPHOLAMBAN; PHOSPHORUS 32; PROTEIN KINASE (CALCIUM,CALMODULIN);

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; HAMSTER; HEART CONTRACTION; HEART FUNCTION; HEART WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CARDIOMYOPATHY, DILATED; CRICETINAE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; MALE; MUSCLE CONTRACTION; MYOCYTES, CARDIAC; PHOSPHORYLATION; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

ANIMALIA; CRICETINAE;

EID: 6044226893     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00155.2004     Document Type: Article

References (44)

1. 2+ pumps in heart and diaphragm of cardiomyopathic hamster: effects of perindopril. Am J Physiol Heart Circ Physiol 268: H1947-H1953, 1995.
2. Bassani JW, Bassani RA, and Bers DM. Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms. J Physiol 476: 279-293, 1994.
3. Bers DM. Ca transport during contraction and relaxation in mammalian ventricular muscle. In: Alterations of Excitation-Contraction Coupling in the Failing Human Heart, edited by Hasenfuss G and Just H. New York: Springer, 1998, p. 1-16.
4. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
5. Davis BA, Schwartz A, Samaha FJ, and Kranias EG. Regulation of cardiac sarcoplasmic reticulum calcium transport by calcium-calmodulin-dependent phosphorylation. J Biol Chem 258: 13587-13591, 1983.
6. Fabiato A. Computer program for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol 157: 378-417, 1988.
7. Fatkin D and Graham RM. Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 82: 945-980, 2002.
8. Finkel MS, Shen L, Romeo RC, Oddis CV, and Salama G. Radioligand binding and inotropic effects of ryanodine in the cardiomyopathic Syrian hamster. J Cardiovasc Pharmacol 19: 610-617, 1992.
9. Fonarow GC. Pathogenesis and treatment of cardiomyopathy. Adv Intern Med 47: 1-45, 2001.
10. Franz WM, Muller OJ, and Katus HA. Cardiomyopathies: from genetics to the prospect of treatment. Lancet 358: 1627-1637, 2001.
11. Hoshijima M, Ikeda Y, Iwanaga Y, Minamisawa S, Date MO, Gu Y, Iwatate M, Li M, Wang L, Wilson JM, Wang Y, Ross J Jr, and Chien KR. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med 8: 864-871, 2002.
12. Hwang JJ, Dzau VJ, and Liew CC. Genomics and the pathophysiology of heart failure. Curr Cardiol Rep 3: 198-207, 2001.
13. 2+ uptake by the cardiac sarcoplasmic reticulum. Biochem J 331: 245-249, 1998.
14. Komajda M, Charron P, and Tesson F. Genetic aspects of heart failure. Eur J Heart Fail 1: 121-126, 1999.
15. Koss LK and Kranias EG. Phospholamban: A prominent regulator of myocardial contractility. Circ Res 79: 1059-1063, 1996.
16. Kranias EG. Regulation of calcium transport by protein phosphatase activity with cardiac sarcoplasmic reticulum. J Biol Chem 260: 11006-11010, 1985.
17. Lachnit WG, Phillips M, Cayman KJ, and Pessah IN. Ryanodine and dihydropyridine binding patterns and ryanodine receptor mRNA levels in myopathic hamster heart. Am J Physiol Heart Circ Physiol 267: H1205-H1213, 1994.
18. Le Peuch CJ, Haiech J, and Demaille JG. Concerted regulation of cardiac sarcoplasmic reticulum by cyclic adenosine monophosphate dependent and calcium-calmodulin-dependent phosphorylation. Biochemistry 18: 5150-5157, 1979.
19. MacGowan GA and McNamara DM. New molecular insights into heart failure and cardiomyopathy: potential strategies and therapies. Ir J Med Sci 171: 99-104, 2002.
20. MacLennan DH and Kranias EG. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4: 566-577, 2003.
21. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just II, and Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92: 778-784, 1995.
22. 2+ uptake in human failing left ventricular myocardium. J Heart Lung Transplant 21: 366-373, 2002.
23. Mitsuhashi S, Saito N, Watano K, Igarashi K, Tagami S, Shima H, and Kikuchi K. Defect of delta-sarcoglycan gene is responsible for development of dilated cardiomyopathy of a novel hamster strain, J2N-k: calcineurin/PP2B activity in the heart of J2N-k hamster. J Biochem (Tokyo) 134: 269-276, 2003.
24. Nagano M, Kato M, Nagai M, and Yang J. Protective effect of ACE- and kininase-inhibitor on the onset of cardiomyopathy. Basic Res Cardiol 86: 187-195, 1991.
25. Nakamura TY, Iwata Y, Sampaolesi M, Kanada H, Saito N, Artman M, Coetzee WA, and Shigekawa M. Stretch-activated cation channels in skeletal muscle myotubes from sarcoglycan-deficient hamsters. Am J Physiol Cell Physiol 281: C690-C699, 2001.
26. 2+/calmodulin-protein kinase phosphorylation of cardiac SR proteins in ischemia-reperfusion. Am J Physiol Cell Physiol 277: C384-C391, 1999.
27. 2+/calmodulin-dependent protein kinase is altered in heart failure. Circ Res 86: 596-605, 2000.
28. 2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes 50: 2133-2138, 2001.
29. O'Brien PJ, Moe GW, Nowack LM, Grima EA, and Armstrong PW. Sarcoplasmic reticulum Ca-release channel and ATP synthesis activities are early myocardial markers of heart failure produced by rapid pacing in dogs. Can J Physiol Pharmacol 72: 999-1006, 1994.
30. Rapundalo ST. Cardiac protein phosphorylation: functional and pathophysiological correlates. Cardiovasc Res 38: 559-588, 1998.
31. Sakamoto A, Abe M, and Masaki T. Delineation of genomic deletion in cardiomyopathic hamster. FEBS Lett 447: 124-128, 1999.
32. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Mutakani Y, Masak T, Toyo-oka T, and Hanaoka F. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 94: 13873-13878, 1997.
33. 2+ pump ATPase. J Biol Chem 267: 1674-1679, 1992.
34. Schmidt U, Hajjar RJ, Helm PA, Kim CS, and Gwathmey JK. Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic function in human heart failure. J Mol Cell Cardiol 30: 1929-1937, 1998.
35. 2+-sensitivity of SERCA 2a in failing human myocardium due to reduced serine-16 phospholamban phosphorylation. J Mol Cell Cardiol 31: 479-491, 1999.
36. Shaw T, Elliott P, and McKenna WJ. Dilated cardiomyopathy: a genetically heterogeneous disease. Lancet 360: 654-655, 2002.
37. Steenaart NA, Gamin JR, Di Salvo J, and Kranias EG. The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme. Arch Biochem Biophys 293: 17-24, 1992.
38. Takagi C, Urasawa K, Yoshida I, Takagi Y, Kaneta S, Nakano N, Onozuka H, and Kitabatake A. Enhanced GRK5 expression in the hearts of cardiomyopathic hamsters, J2N-k. Biochem Biophys Res Commun 262: 206-210, 1999.
39. Takeda N. Cardiomyopathy: molecular and immunological aspects. Int J Mol Med 11: 13-16, 2003.
40. Temsah RM, Netticadan T, Chapman D, Takeda S, Mochizuki S, and Dhalla NS. Alterations in sarcoplasmic reticulum function and gene expression in the ischemic-reperfused rat heart. Am J Physiol Heart Circ Physiol 277: H584-H594, 1999.
41. Towbin JA and Bowles NE. The failing heart. Nature 415: 227-233, 2002.
42. 2+-release channels during development of heart failure in cardiomyopathic hamsters. Am J Physiol Heart Circ Physiol 274: H1-H7, 1998.
43. Whitmer JT, Kumar P, and Solaro RJ. Calcium transport properties of cardiac sarcoplasmic reticulum from cardiomyopathic Syrian hamsters (BIO 53.58 and 14.6): evidence for a quantitative defect in dilated myopathic hearts not evident in hypertrophic hearts. Circ Res 62: 81-5, 1988.
44. Yamaguchi F, Sanbe A, and Takeo S. Cardiac sarcoplasmic reticular function in rats with chronic heart failure following myocardial infarction. J Mol Cell Cardiol 29: 753-763, 1997.